- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 30, 2025 | 25.82M sh |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $68M |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $102M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $57.4M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $65.96M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $322.02M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $349.85M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $538.33M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $601.27M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $660.75M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $668.65M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $1.24B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $1.17B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $1.84B |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 25.85M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 25.85M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $7.19M |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $4.13M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $19.24M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.90 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $1.49 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.90 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $1.49 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $55.1M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $109.07M |
| Net Income | Q2 2025 · Mar 31, 2024 | $23.22M |
| Net Income | Q2 2025 · Mar 31, 2024 | $38.39M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $152.35M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $286.5M |
| Revenue | Q2 2025 · Mar 31, 2024 | $249.13M |
| Revenue | Q2 2025 · Mar 31, 2024 | $467.44M |